Semler Scientific Inc (OTCMKTS:SMLR) shares passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $44.41 and traded as low as $41.50. Semler Scientific shares last traded at $43.20, with a volume of 10,774 shares trading hands.
Separately, ValuEngine lowered shares of Semler Scientific from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th.
The company has a 50 day simple moving average of $44.57 and a 200-day simple moving average of $44.66. The stock has a market cap of $288.67 million, a price-to-earnings ratio of 64.86, a P/E/G ratio of 1.46 and a beta of 0.34.
Semler Scientific (OTCMKTS:SMLR) last issued its quarterly earnings results on Wednesday, October 30th. The medical equipment provider reported $0.38 EPS for the quarter, beating analysts’ consensus estimates of $0.29 by $0.09. The company had revenue of $8.90 million for the quarter, compared to analyst estimates of $8.09 million. Semler Scientific had a return on equity of 116.92% and a net margin of 46.11%. On average, equities research analysts anticipate that Semler Scientific Inc will post 1.18 earnings per share for the current year.
In other news, Director Wayne T. Pan sold 2,500 shares of the firm’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $42.81, for a total transaction of $107,025.00. 13.90% of the stock is currently owned by company insiders.
About Semler Scientific (OTCMKTS:SMLR)
Semler Scientific, Inc develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. Its products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Further Reading: Why Invest in Dividend Achievers?
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.